Center Laboratories, Inc.
Research Center Laboratories, Inc. (4123.TWO) on Bullrun: market cap TWD 23.12B, P/E 83.8, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4123.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 23.12B
- P/E83.8
- Dividend yield6.2%
- Financial periodQ2 2026
- RevenueTWD 432.06M
- Net income-TWD 10.45B
- Free cash flow-TWD 11.82M
- Gross margin43.7%
Valuation Snapshot
latest market cap is TWD 23.12B; P/E is 83.8; dividend yield is 6.2%.
Peer valuation comparison
Latest P/E is 83.78x versus a Healthcare sector median of 21.8x (284.4% above).
Latest dividend yield is 6.15% versus a Healthcare sector median of 2.4% (156.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 23.12B | 83.8 | 5.6% | 1.75 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.75 TWD, yield 6.2%.
About Center Laboratories, Inc.
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines.
ETFs that hold Center Laboratories, Inc.
US-listed ETFs
Center Laboratories, Inc. is held by 17 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | 0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | 0.02% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.02% | 0.06% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Center Laboratories, Inc.'s market cap?
Center Laboratories, Inc.'s market capitalization is TWD 23.12B.
What is Center Laboratories, Inc.'s P/E ratio?
Center Laboratories, Inc.'s price-to-earnings (P/E) ratio is 83.8.
Does Center Laboratories, Inc. pay a dividend?
Center Laboratories, Inc. has a dividend yield of 6.2%.
What does Center Laboratories, Inc. do?
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines.